304 related articles for article (PubMed ID: 29103990)
21. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
[TBL] [Abstract][Full Text] [Related]
22. Cryptococcus antigens and immune responses: implications for a vaccine.
Chaturvedi AK; Wormley FL
Expert Rev Vaccines; 2013 Nov; 12(11):1261-72. PubMed ID: 24156284
[TBL] [Abstract][Full Text] [Related]
23. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.
Huang C; Nong SH; Mansour MK; Specht CA; Levitz SM
Infect Immun; 2002 Oct; 70(10):5485-93. PubMed ID: 12228274
[TBL] [Abstract][Full Text] [Related]
24. Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.
Leongson K; Cousineau-Côté V; Goupil M; Aumont F; Sénéchal S; Gaboury L; Jolicoeur P; Kronstad JW; de Repentigny L
Infect Immun; 2013 Apr; 81(4):1100-13. PubMed ID: 23340313
[TBL] [Abstract][Full Text] [Related]
25. Models for Inducing Experimental Cryptococcosis in Mice.
Castro-Lopez N; Wormley FL
Methods Mol Biol; 2024; 2775():29-46. PubMed ID: 38758309
[TBL] [Abstract][Full Text] [Related]
26. Detection of IgM and IgG antibodies to Cryptococcus neoformans proteins in blood donors and HIV patients with active cryptococcosis.
Chai HC; Tay ST
Mycoses; 2009 Mar; 52(2):166-70. PubMed ID: 18643920
[TBL] [Abstract][Full Text] [Related]
27. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
mBio; 2016 May; 7(3):. PubMed ID: 27165801
[TBL] [Abstract][Full Text] [Related]
28. Pitfalls in Serological Diagnosis of Cryptococcus gattii Infections.
Tintelnot K; Hagen F; Han CO; Seibold M; Rickerts V; Boekhout T
Med Mycol; 2015 Nov; 53(8):874-9. PubMed ID: 26337090
[TBL] [Abstract][Full Text] [Related]
29. Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.
Gibson JF; Johnston SA
Fungal Genet Biol; 2015 May; 78():76-86. PubMed ID: 25498576
[TBL] [Abstract][Full Text] [Related]
30. Cryptococcus gattii polysaccharide capsule: An insight on fungal-host interactions and vaccine studies.
Freitas GJC; Santos DA
Eur J Immunol; 2021 Sep; 51(9):2206-2209. PubMed ID: 34396521
[TBL] [Abstract][Full Text] [Related]
31. Ten challenges on Cryptococcus and cryptococcosis.
Del Poeta M; Casadevall A
Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062
[TBL] [Abstract][Full Text] [Related]
32. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
Fromtling RA; Blackstock R; Hall NK; Bulmer GS
Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
Wormley FL; Cox GM; Perfect JR
Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
[TBL] [Abstract][Full Text] [Related]
34. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.
Hoy JF; Murphy JW; Miller GG
J Infect Dis; 1989 Jan; 159(1):116-9. PubMed ID: 2462601
[No Abstract] [Full Text] [Related]
35. Vaccines and Protective Immune Memory against Cryptococcosis.
Ueno K; Yanagihara N; Shimizu K; Miyazaki Y
Biol Pharm Bull; 2020; 43(2):230-239. PubMed ID: 32009111
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii.
Ueno K; Kinjo Y; Okubo Y; Aki K; Urai M; Kaneko Y; Shimizu K; Wang DN; Okawara A; Nara T; Ohkouchi K; Mizuguchi Y; Kawamoto S; Kamei K; Ohno H; Niki Y; Shibuya K; Miyazaki Y
Infect Immun; 2015 Apr; 83(4):1577-86. PubMed ID: 25644007
[TBL] [Abstract][Full Text] [Related]
37. Epitope-Based Immunoinformatic Approach on Heat Shock 70 kDa Protein Complex of
Elhassan RM; Alsony NM; Othman KM; Izz-Aldin DT; Alhaj TA; Ali AA; Abashir LA; Ahmed OH; Hassan MA
J Immunol Res; 2021; 2021():9921620. PubMed ID: 34471644
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection.
Rodrigues ML; Shi L; Barreto-Bergter E; Nimrichter L; Farias SE; Rodrigues EG; Travassos LR; Nosanchuk JD
Clin Vaccine Immunol; 2007 Oct; 14(10):1372-6. PubMed ID: 17715331
[TBL] [Abstract][Full Text] [Related]
39. Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans.
Cheng PY; Sham A; Kronstad JW
Infect Immun; 2009 Oct; 77(10):4284-94. PubMed ID: 19635827
[TBL] [Abstract][Full Text] [Related]
40. Semisynthetic Glycoconjugate Vaccine Candidates against
Crawford CJ; Liporagi-Lopes L; Coelho C; Santos Junior SR; Moraes Nicola A; Wear MP; Vij R; Oscarson S; Casadevall A
ACS Infect Dis; 2024 Jun; 10(6):2089-2100. PubMed ID: 38819951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
